Company profile: Modular Genetics
1.1 - Company Overview
Company description
- Provider of an automated gene engineering system that accelerates product development and reduces costs by enabling simultaneous development of multiple products, and engineered microorganisms that synthesize chemicals from renewable raw materials such as sugar to support a renewable materials-based economy.
Products and services
- Engineered Microorganisms for Sustainable Chemistry: Custom-engineered microbes that synthesize target chemicals from renewable raw materials like sugar, directly supporting a transition to a renewable materials-based economy
- Automated Gene Engineering System: Industrial-grade platform that accelerates product development and reduces costs by automating gene engineering to enable simultaneous development of multiple products
- Automated Gene Engineering System Development: Development-focused service that architects and builds automated gene engineering systems designed to create new products, leveraging automation to coordinate multi-product development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Modular Genetics
Bioanalytical Systems
HQ: United States
Website
- Description: Provider of contract development services and specialized equipment for pharmaceutical, medical research, and biotechnology organizations, including electrochemistry and low-stress in vivo sampling products (electrodes, cell packages, accessories), electrochemical analyzers (potentiostats, galvanostats, EIS), animal catheters and extenders, educational electrochemistry kits, and the Raturn movement-responsive caging system for tether-based applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioanalytical Systems company profile →
Stilla Technologies
HQ: France
Website
- Description: Provider of digital PCR solutions to accelerate next-generation genetic testing, including the Nio System, an all-in-one 7-color, continuous-loading instrument for high-throughput analysis; the naica System, a multiplex dPCR platform with up to six fluorescent channels; ready-to-use digital PCR kits and assays; chips and reagents; and analysis software for image analysis and data export.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stilla Technologies company profile →
SAW Instruments
HQ: Germany
Website
- Description: Provider of innovative analytical systems for the life sciences market, enabling label-free analysis of molecular biomolecular interactions and combining stability, ease of use, and high sensitivity; develops, manufactures, and sells equipment for life sciences applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SAW Instruments company profile →
Native Antigen
HQ: United Kingdom
Website
- Description: Provider of native and recombinant viral and bacterial antigens, antibodies and immunoassays, specialising in their development and manufacture. Antigens are used by leading pharmaceutical companies and IVD manufacturers in vaccine research and serology, where proper folding and glycosylation are vital.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Native Antigen company profile →
PrimeraDx
HQ: United States
Website
- Description: Provider of multiplexed infectious disease assays and Scalable Target Amplification Routine technology for simultaneous quantitative measurement of multiple nucleic acid targets. Offers the ICEPlex system combining PCR and capillary electrophoresis, companion diagnostics, a C. difficile assay, ViraQuant for virus quantification, translational medicine research solutions, and pharma quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PrimeraDx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Modular Genetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Modular Genetics
2.2 - Growth funds investing in similar companies to Modular Genetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Modular Genetics
4.2 - Public trading comparable groups for Modular Genetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →